Lara K. Mahal
Auto-generated profile, based on publicly available information

Lara K. Mahal

University of Alberta

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 1997 in Science
Verified
Journal Article
Open access
PDF file
LMLara K. Mahal
Lara K. Mahal
KYKevin J. Yarema
Kevin J. Yarema
CBCarolyn R. Bertozzi
Carolyn R. Bertozzi
Cell surface oligosaccharides can be engineered to display unusual functional groups for the selective chemical remodeling of cell surfaces. An unnatural derivative of N -acetylmannosamine, which has a ketone group, was converted to the corresponding sialic acid and incorporated into cell surface oligosaccharides metabolically, resulting in the cell surface display of ketone groups. The ketone group on the cell surface can then be covalently ligated under physiological conditions with molecules carrying a complementary reactive functional group such as the hydrazide. Cell surface reactions of this kind should prove useful in the introduction of new recognition epitopes, such as peptides, oligosaccharides, or small organic molecules, onto cell surfaces and in the subsequent modulation of cell-cell or cell–small molecule binding events. The versatility of this technology was demonstrated by an example of selective drug delivery. Cells were decorated with biotin through selective conjugation to ketone groups, and selectively killed in the presence of a ricin A chain–avidin conjugate.

2 April 2018 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
MGMichael M. Gaschler
Michael M. Gaschler
AAAlexander A. Andia
Alexander A. Andia
HLHengrui Liu
Hengrui Liu
JCJoleen M. Csuka
Joleen M. Csuka
BHBrisa Hurlocker
Brisa Hurlocker
BSBrent R. Stockwell
Brent R. Stockwell

10 April 2017 in Nature Medicine
Verified
Journal Article
Open access
PDF file
DDDonnele Daley
Donnele Daley
VMVishnu R Mani
Vishnu R Mani
NMNavyatha Mohan
Navyatha Mohan
NANeha Akkad
Neha Akkad
AOAtsuo Ochi
Atsuo Ochi
GMGeorge Miller
George Miller
Activation of dectin-1-dependent signaling in macrophages through ligation by galectin 9 promotes an immunosuppressive, protumorigenic microenvironment in pancreatic adenocarcinoma (PDA). Blocking dectin 1 ligation restores anti-tumor immunity and delays tumor growth, thus offering a novel strategy for improving the effectiveness of immunotherapy in patients with PDA. The progression of pancreatic oncogenesis requires immune-suppressive inflammation in cooperation with oncogenic mutations. However, the drivers of intratumoral immune tolerance are uncertain. Dectin 1 is an innate immune receptor crucial for anti-fungal immunity, but its role in sterile inflammation and oncogenesis has not been well defined. Furthermore, non-pathogen-derived ligands for dectin 1 have not been characterized. We found that dectin 1 is highly expressed on macrophages in pancreatic ductal adenocarcinoma (PDA). Dectin 1 ligation accelerated the progression of PDA in mice, whereas deletion of Clec7a—the gene encoding dectin 1—or blockade of dectin 1 downstream signaling was protective. We found that dectin 1 can ligate the lectin galectin 9 in mouse and human PDA, which results in tolerogenic macrophage programming and adaptive immune suppression. Upon disruption of the dectin 1–galectin 9 axis, CD4+ and CD8+ T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity. These data suggest that targeting dectin 1 signaling is an attractive strategy for developing an immunotherapy for PDA.

27 January 2022 in ACS Chemical Biology
Verified
Journal Article
Open access
DBDaniel Bojar
Daniel Bojar
LMLawrence Meche
Lawrence Meche
GMGuanmin Meng
Guanmin Meng
WEWilliam Eng
William Eng
DSDavid F. Smith
David F. Smith
LMLara K. Mahal
Lara K. Mahal
Glycans are critical to every facet of biology and medicine, from viral infections to embryogenesis. Tools to study glycans are rapidly evolving; however, the majority of our knowledge is deeply dependent on binding by glycan binding proteins (e.g., lectins). The specificities of lectins, which are often naturally isolated proteins, have not been well-defined, making it difficult to leverage their full potential for glycan analysis. Herein, we use a combination of machine learning algorithms and expert annotation to define lectin specificity for this important probe set. Our analysis uses comprehensive glycan microarray analysis of commercially available lectins we obtained using version 5.0 of the Consortium for Functional Glycomics glycan microarray (CFGv5). This data set was made public in 2011. We report the creation of this data set and its use in large-scale evaluation of lectin–glycan binding behaviors. Our motif analysis was performed by integrating 68 manually defined glycan features with systematic probing of computational rules for significant binding motifs using mono- and disaccharides and linkages. Combining machine learning with manual annotation, we create a detailed interpretation of glycan-binding specificity for 57 unique lectins, categorized by their major binding motifs: mannose, complex-type N-glycan, O-glycan, fucose, sialic acid and sulfate, GlcNAc and chitin, Gal and LacNAc, and GalNAc. Our work provides fresh insights into the complex binding features of commercially available lectins in current use, providing a critical guide to these important reagents.

1 July 2011 in Cancer Cell
Verified
Journal Article
Closed access
AGAvital Gaziel-Sovran
Avital Gaziel-Sovran
Miguel F SeguraMiguel F Segura
Miguel F Segura
RMRaffaella Di Micco
Raffaella Di Micco
MCMary K. Collins
Mary K. Collins
DHDouglas Hanniford
Douglas Hanniford
EHEva Hernando
Eva Hernando

1 June 2017 in Cancer Cell
Verified
Journal Article
Closed access
PAPraveen Agrawal
Praveen Agrawal
BFBarbara Fontanals-Cirera
Barbara Fontanals-Cirera
ESElena Sokolova
Elena Sokolova
SJSamson Jacob
Samson Jacob
CVChristopher A. Vaiana
Christopher A. Vaiana
EHEva Hernando
Eva Hernando